Victoria Shelton, MSc^1*, Keren Isaev, MSc^2*, Ting Liu, PhD^2*, Anjali Silva, PhD, MSc, BSc^2*, Rajesh Detroja^2*, Mehran Bakhtiari, MSc^2*, Lourdes Calvente, MD^2*, Michael Hong, MSc^2*, Saloni Modi^2*, Samantha A Hershenfeld, BSc², Maja Ludvigsen, PhD^3*, Francesco Annibale d'Amore, MD, DMSc⁴, Marianne Brodtkorb, MD, PhD^5*, Nathalie A. Johnson, MD, PhD,⁶, Tara Baetz, MD^7*, David LeBrun, MD⁸, Josh Tobin^9*, Maher K. Gandhi, PhD, FRACP, FRCPath¹⁰, Andrew J. Mungall, PhD^11*, Christian Steidl^12*, Jan Delabie, MD, PhD^2*, Rosemarie Tremblay-Lemay, MD, MSc^2*, Brad S. Kahl, MD¹³, Andrew M Evens, DO, MSc¹⁴ and Robert Kridel, MD²

¹University Health Network, Princess Margaret Cancer Center, Richmond Hill, ON, Canada
²University Health Network, Princess Margaret Cancer Center, Toronto, ON, Canada
³Department of Clinical Medicine, Aarhus University, Aarhus, Denmark
⁴Department of Hematology, Aarhus University Hospital, Aarhus, Denmark
⁵Department of Oncology, Oslo University Hospital, Oslo, Norway
⁶Jewish General Hospital, Montreal, QC, Canada
⁷Kingston General Hospital, Kingston, ON, Canada
⁸Queen's University, Department of Pathology and Molecular Medicine, Kingston, ON, Canada
⁹Mater Research University of Queensland, Department of Haematology, Princess Alexandra Hospital, Brisbane, Australia
¹⁰Blood Cancer Research Group, Mater Research, University of Queensland, Brisbane, QLD, Australia
¹¹Canada's Michael Smith Genome Sciences Center, BC Cancer Agency and Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada
¹²Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada
¹³Division of Oncology, Washington University School of Medicine in St. Louis, Saint Louis, MO
¹⁴Rutgers Cancer Institute of New Jersey, New Brunswick, NJ

Jasper Wong^1,2*, Brett Collinge^3*, Laura K Hilton, PhD^1*, Susana Ben-Neriah, MSc^1*, Merrill Boyle^1*, Barbara Meissner^1*, Kelly Mekwunye^1*, Graham W. Slack, MD⁴, Pedro Farinha, MD, PhD^1*, Jeffrey W. Craig, MD, PhD^4*, Laurie H. Sehn, MD, MPH¹, Diego Villa, MD¹, Alina S. Gerrie, MD, MPH, FRCPC¹, Andrew J. Mungall, PhD^5*, Christian Steidl^1*, James R. Cook, MD, PhD⁶, Andrew L. Feldman, MD⁷, Lisa M. Rimsza, MD⁸, Kerry J. Savage, MD, MSc, FRCPC¹, Ryan D. Morin^1,9,10 and David W. Scott, PhD, MD, FRACP, FRCPA¹

¹Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada
²Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada
³Centre for Lymphoid Cancer, British Columbia Cancer Centre For Lymphoid Cancer, Vancouver, BC, Canada
⁴Centre for Lymphoid Cancer, Department of Pathology, BC Cancer, Vancouver, BC, Canada
⁵Canada's Michael Smith Genome Sciences Center, BC Cancer Agency and Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada
⁶Department of Pathology and Laboratory Medicine, Cleveland Clinic Foundation, Cleveland, OH
⁷Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
⁸Division of Hematopathology, Mayo Clinic - Scottsdale, Scottsdale, AZ
⁹Simon Fraser University, Burnaby, BC, CAN
¹⁰Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada

Zhen Han^1*, Xiwei Wu, PhD^2*, Yate-Ching Yuan, PhD^3*, Hanjun Qin, PhD^4*, Chingyu Su^2*, Jasmine Zain, MD⁵, Oleg E Akilov, MD^6*, Steve T Rosen, MD⁷, Mingye Feng, PhD^8* and Christiane Querfeld, MD, PhD^1,9

¹Division of Dermatology, City of Hope, Duarte, CA
²Beckman Research Institute, City of Hope, Duarte, CA
³Translational Bioinformatics, City of Hope National Medical Center, Duarte, CA
⁴Integrative Genomics Core, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA
⁵City of Hope Comprehensive Cancer Center, Duarte, CA
⁶Dept. of Dermatology, University of Pittsburgh, Pittsburgh, PA
⁷Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
⁸Department of Immuno-Oncology, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA
⁹Department of Pathology, City of Hope, Duarte, CA

Jennifer R Chapman-Fredricks, MD^1*, Devang Thakkar^2*, Juan Pablo Alderuccio, MD³, Kikkeri N Naresh, MD, MBBS⁴, Sarah L. Ondrejka, DO^5*, Eric D. Hsi, MD⁶, Mina L Xu, MD^7*, Nathan Paulson^8*, Jean L. Koff, MD, MSc⁹, David L. Jaye, MD¹⁰, Jonathon B. Cohen, MD, MS¹¹, Anne Ortved Gang, MD, PhD^12*, Rebecca J Leeman-Neill, MD, PhD¹³, Tushar Dave, MS^14*, Lanie Happ, PhD^15*, Cassandra Love¹⁴, Sasan Zandi, MD, PhD¹⁶, Hina Naushad, MD^17*, Emily F Mason, MD, PhD^18,19*, Abner Louissaint Jr., MD, PhD²⁰, Haley Martin^20*, Choon Kiat Ong, PhD²¹, Raju Pillai, MD^22*, Mette Ø Pedersen, MD PhD^23*, C. Cameron Yin, MD, PhD²⁴, William Choi, MBBS, MRCP²⁵, Rex Kwok Him Au-Yeung, MBBS^26*, Marja-Liisa Karjalainen-Lindsberg, MD, PhD^27*, Amy Chadburn, MD²⁸, Vincent Sarno^29*, Matthew McKinney, MD³⁰, Payal Sojitra, MD^31*, Andrew G Evans, MD, PhD³², Amir Behdad, MD^33*, Carlos Galvez, MD³⁴, Chee Leong Cheng, FRCPA, FRCPath, MBBS^35*, Magdalena Czader, MD, PhD³⁶, Jiong Yan^37*, Sandeep S. Dave, MD, MS³⁸ and Izidore S. Lossos, MD³⁹

¹Division of Hematopathology, University of Miami, Sylvester Comprehensive Cancer Center, Miami
²Duke University, Durham, NC
³Division of Hematology, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, FL
⁴Fred Hutchinson Cancer Center, Seattle, WA
⁵Cleveland Clinic, Cleveland, OH
⁶Wake Forest Baptist Medical Center, Winston Salem, NC
⁷Yale University School of Medicine and Yale Cancer Center, New Haven, CT
⁸Department of Pathology, Stanford University, Palo Alto, CA
⁹Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA
¹⁰Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Dunwoody, GA
¹¹Department of Hematology and Medical Oncology, Emory University, Atlanta, GA
¹²Dept. of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
¹³Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY
¹⁴Duke University Medical Center, Durham, NC
¹⁵Data Driven Bioscience, Durham, NC
¹⁶Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada
¹⁷University of Nebraska Medical Center, Omaha, NE
¹⁸De, Vanderbilt University Medical Center, Nashville, TN
¹⁹Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville
²⁰Massachusetts General Hospital, Boston, MA
²¹National Cancer Center Singapore, Singapore, Singapore
²²Department of Pathology, City of Hope National Medical Center, Duarte, CA
²³Copenhagen University Hospital, Herlev, Denmark
²⁴The University of Texas MD Anderson Cancer Center, Houston, TX
²⁵Department of Pathology, Hong Kong Sanatorium and Hospital, Hong Kong, HKG
²⁶Department of Pathology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
²⁷Helsinki University Hospital, Helsinki, Finland
²⁸Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY
²⁹Weill Cornell Medicine, New York, NY
³⁰Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC
³¹Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ
³²Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY
³³Northwestern University Feinberg School of Medicine, Chicago, IL
³⁴Division of Hematology and Oncology, University of Illinois at Chicago, Chicago, IL
³⁵National Cancer Centre Singapore, Singapore, Singapore
³⁶Indiana University School of Medicine, Indianapolis, IN
³⁷University of Toronto, Toronto, ON, Canada
³⁸Duke Cancer Institute, Duke University, Durham, NC
³⁹Division of Hematology, Department of Medicine, Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL

Lynda Villagomez, MD¹, Porsha Smith, PhD^2*, Fengting Yan, MD, PhD^2*, Victor Chen, BS², Shelby Sloan, BS^2,3, John T. Patton, MD, PhD^2*, Mackenzie Long, DVM^2,3, Fiona Brown, BS², Elshafa H. Ahmed, DVM, PhD², Natarajan Muthusamy, DVM, PhD², Vincenzo Coppola, MD^4*, Anjali Mishra, PhD⁵, Kris Vaddi, PhD⁶, Peggy Scherle, PhD⁶, Rosa Lapalombella, PhD², Lapo Alinari, MD, PhD² and Robert A. Baiocchi, MD, PhD²

¹Department of Pediatrics, Division of Hematology and Oncology, The Ohio State University and Nationwide Children's Hospital, Columbus, OH
²Department of Internal Medicine, Division of Hematology, College of Medicine, The Ohio State University, Columbus, OH
³Department of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH
⁴Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH
⁵Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA
⁶Research and Development, Prelude Therapeutics, Wilmington, DE

Alexandra Dolníková, MSc^1*, Dmitry Kazantsev, PhD^1*, Diana Malarikova, MD^1,2*, Eva Pokorna^1*, Dana Sovilj^3*, Cristina Daniela Kelemen, PhD^3*, Ladislav Andera, MSc, PhD^3*, Marek Trněný, MD² and Pavel Klener Jr., Prof., MD, PhD^1,2*

¹Institute of Pathological Physiology, First Faculty of Medicine, Charles University, Prague, Czech Republic
²First Department of Internal Medicine - Hematology, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic
³Institute of Biotechnology, Czech Academy of Sciences, Vestec, Czech Republic

Yu Qiu^1,2*, Xiaoshuang Wang^3*, Yuan Yao^4*, Yanmin Si^5*, Xuezhu Wang^4*, Mingnan Jia^6*, Daobin Zhou^4*, Jia Yu^7*, Jian Li, MD⁴ and Xin-xin Cao, MD^4*

¹Peking Union Medical College Hospital, Beijing, China
²China-Japan Friendship Hospital, Beijing, China
³Chinese Academy of Medical Science, Beijing, CHN
⁴Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
⁵Chinese Academy of Medical Sciences and Peking Union Medical College, Beijng, CHN
⁶Peking Union Medical College Hospital, Chinese Academy Medical Society&Pekin, Beijing, CHN
⁷Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences (CAMS), School of Basic Medicine Peking Union Medical College, Beijing, China

Robert J. Hayashi^1*, Michelle L. Hermiston, MD, PhD², David T. Teachey, MD^3,4, Meenakshi Devidas, PhD, MBA⁵, Brent L. Wood, MD PhD⁶, Zhiguo Chen, MS^7*, Robert D Annett, Ph.D.^8*, Barbara L Asselin, MD⁹, Keith J August, MD, MS¹⁰, Steve Y Cho, MD^11*, Kimberly P. Dunsmore, MD^12*, Jason L. Freedman, MD^13*, Paul J. Galardy, MD¹⁴, Paul Harker-Murray, MD, PhD¹⁵, Terzah M. Horton, MD, PhD¹⁶, Alok I Jaju, MD^17*, Allison Lam, BCPS^18*, Yoav H. Messinger, MD¹⁹, Rodney R. Miles, MD, PhD²⁰, Maki Okada, RN^18*, Samir I Patel, MD^21*, Eric S Schafer, MD^22*, Tal Schechter-Finkelstein, MD²³, Kristin A. Shimano, MD²⁴, Neelam Singh, PhD^25*, Amii C. Steele, PhD^26*, Maria Luisa Sulis, MD²⁷, Sarah L Vargas, PhD^28*, Stuart S. Winter, MD²⁹, Charlotte Wood, CCRP^30*, Patrick A Zweidler-McKay, MD, PhD³¹, Mignon L. Loh, MD³², Stephen P. Hunger, MD⁴, Elizabeth A. Raetz, MD³³, Catherine M Bollard, MD³⁴ and Carl Allen, MD³⁵

¹Pediatric Hematology/Oncology (PD), St Louis, MO
²Pediatric Hematology Oncology, University of California San Francisco, San Francisco, CA
³Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
⁴Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
⁵Department of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, TN
⁶Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA
⁷Department of Biostatistics, University of Florida, Gainesville, FL
⁸Pediatrics, University of New Mexico, Albuquerque,, NM
⁹Golisano Children's Hospital at URMC, University of Rochester Strong Memorial Hospital, Rochester, NY
¹⁰Chidren's Mercy Hospital, Kansas City, MO
¹¹Wisconsin Institute for Medical Research, Madison, WI
¹²Virginia Tech Carilion School of Medicine, Roanoke, VA
¹³Department of Pediatrics, Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
¹⁴Pediatric Hematology and Oncology, Mayo Clinic, Rochester, MN
¹⁵Midwest Children's Cancer Center, Milwaukee, WI
¹⁶Baylor College of Medicine, Houston, TX
¹⁷Lurie Children's Hospital, Chicago, IL
¹⁸Miller Children's and Women’s Hospital, Long Beach, CA
¹⁹Children's Hospitals and Clinics of Minnesota, Minneapolis, MN
²⁰Dept. of Pathology and ARUP Institute for Clinical & Experimental Pathology, University of Utah, Primary Children's Hospital, Salt Lake City, UT
²¹University of Alberta- Stollery Children’s Hospital, Edmonton, AB, Canada
²²Baylor College of Medicine, Texas Children's Hospital, Houston, TX
²³Division of Hematology/Oncology, Department of Pediatrics, University of Toronto, The Hospital for Sick Children, Toronto, Canada
²⁴Department of Pediatrics, University of California Benioff Children’s Hospital, San Francisco, CA
²⁵Michigan State University Clinical Center, Lansing, MI
²⁶Carolinas Medical Center/Levine Cancer Institute, Charlotte, NC
²⁷Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY
²⁸Children's Oncology Group, Monrovia, CA
²⁹Research Institute and Cancer and Blood Disorders Program, Children's Minnesota, Eagan, MN
³⁰Children's Oncology Group Data Center, Gainesville, FL
³¹ImmunoGen, Inc., Waltham, MA
³²Department of Pediatrics, Division of Pediatric Hematology/Oncology, University of California Benioff Children’s Hospital, Seattle, WA
³³Division of Pediatric Hematology and Oncology, Stephen D. Hassenfeld Children's Center for Cancer and Blood Disorders, NYU Langone Health, New York, NY
³⁴Center for Cancer and Immunology Research, Children's National Medical Center, Washington, DC
³⁵Texas Children's Hospital, Houston, TX

Petra Johanna Nygren^1,2*, Aino Häkkinen^1,2*, Daehong Kim, PhD^1,2*, Timo Jarvinen^1,2*, Fumihiro Ishida, MD, PhD³, Stefania Bortoluzzi, PhD^4*, Andrea Binatti^4*, Vanessa Rebecca Gasparini^5*, Renato Zambello, MD^6*, Mikko Myllymäki, MD, PhD^1,2*, Seishi Ogawa, MD, PhD^7,8, Yusuke Okuno, MD, PhD⁹, Hiroshi Kimura, M.D., Ph. D.^10*, John Chan, MD^11*, Olli Dufva^1,2*, Satu Mustjoki, MD, PhD^1,2 and Matti Kankainen, PhD^1,2*

¹Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland
²Translational Immunology Research Program, University of Helsinki, Helsinki, Finland
³Department of Biomedical Laboratory Sciences, Shinshu University School of Medicine, Matsumoto, Japan
⁴Department of Molecular Medicine, University of Padova, Padova, Italy
⁵University School of Medicine, Department of Medicine, Hematology and Clinical Immunology Branch, Padova, Italy
⁶Department of Medicine, Hematology and Clinical Immunology Branch, University of Padova, Padova, Italy
⁷Center for Hematology and Regenerative Medicine, Department of Medicine (MedH), Karolinska Institutet, Huddinge, Sweden
⁸Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
⁹Medical Genomics Center, Nagoya University Hospital, Nagoya, Japan
¹⁰Department of Virology, Nagoya University Graduate School of Medicine, Nagoya, Japan
¹¹Department of Pathology, City of Hope National Medical Center, Duarte, CA

Angelo Cabal, BA¹, Menglei Zhu, MD, PhD^2*, Manik Uppal, MD^3*, Erel Joffe, MD, MSc⁴, Connie Lee Batlevi, MD, PhD¹, Matthew J. Matasar, MD, MS⁵, Michelle Okwali, MPH^4*, Ahmet Dogan, MD, PhD², Andrew D. Zelenetz, MD, PhD¹, Gilles Salles, MD, PhD¹ and Niloufer Khan, MD⁴

¹Memorial Sloan Kettering Cancer Center, New York, NY
²Department of Pathology and Laboratory Medicine, Hematopathology Service, Memorial Sloan Kettering Cancer Center, New York, NY
³Department of Medicine, New York-Presbyterian Hospital/Weill Cornell Medicine, New York, NY
⁴Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁵215 West 90th St, 14E, Memorial Sloan Kettering Cancer Center, New York, NY

Andy Itsara, MD, PhD^1*, Sebastian Scheich, MD^2*, Björn Häupl, PhD^3,4,5*, Xin Yu^2*, Thomas Oellerich, MD^3,4,5* and Louis M. Staudt, MD, PhD²

¹Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
²Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
³German Cancer Research Center and German Cancer Consortium, Heidelberg, Germany
⁴Department of Medicine II, Hematology-Oncology, Goethe University, Frankfurt, Germany
⁵Frankfurt Cancer Institute, Goethe University, Frankfurt, Germany

Pallavi K Galera, MBBS¹, David Qualls, MD², Umut Aypar, PhD^3*, Caroline Kostrzewa^4*, Menglei Zhu, MD, PhD^5*, Jeeyeon Baik^1*, Venkatraman Seshan, PhD^4*, Gilles Salles, MD, PhD⁶ and Ahmet Dogan, MD, PhD¹

¹Department of Pathology and Laboratory Medicine, Hematopathology Service, Memorial Sloan Kettering Cancer Center, New York, NY
²Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, Brookline, MA
³Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
⁵Memorial Sloan Kettering Cancer Center, New York, NY
⁶Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY

Electra Sofou^1,2*, Maria Karypidou^2*, Laura Zaragoza-Infante^2*, Nikolaos Pechlivanis^2*, Fotis Psomopoulos^2*, Elisavet Georgiou^1*, Evgeny Arons^3*, Robert J. Kreitman³, Anastasia Chatzidimitriou^2* and Kostas Stamatopoulos²

¹Laboratory of Biological Chemistry, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece
²Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece
³Laboratory of Molecular Biology, National Cancer Institute, NIH, Bethesda, MD

Alison Rutz^*, Shelby Lund, BS^*, Jinda Guidinger, BS^*, Kennedee Weber^*, Aidan Forberg^* and Keenan T. Hartert, PhD

College of Science Engineering and Technology, Minnesota State University, Mankato, Mankato, MN

Navika D. Shukla, MD^1*, Joseph Schroers-Martin, MD², Karan R. Kathuria^3*, Brian Sworder, MD, PhD⁴, Stefan K. Alig, MD³, Matthew J Frank, MD, PhD⁵, David B. Miklos, MD, PhD⁶, Steven Coutre, MD⁷, Maximilian Diehn, MD, PhD^8*, Michael S. Khodadoust, MD PhD³, Mark Roschewski, MD⁹, David M. Kurtz, MD, PhD¹⁰ and Ash A. Alizadeh, MD, PhD¹¹

¹Department of Medicine, University of Chicago, Chicago, IL
²Stanford University, Stanford
³Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA
⁴Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA
⁵Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Palo Alto, CA
⁶Department of Medicine, Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA
⁷Stanford University School of Medicine, Stanford, CA
⁸Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA
⁹Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
¹⁰Stanford University, Palo Alto, CA
¹¹Divisions of Oncology and Hematology, Department of Medicine, Stanford University School of Medicine, San Mateo, CA

Yuxuan Che^*, Wei Wang, PhD^*, Yang Liu, PhD^*, Heng-Huan Lee, PhD^*, Yijing Li, MS^*, Zhihong Chen^*, Joseph McIntosh, BS^*, Changying Jiang, PhD, Yixin Yao, PhD and Michael Wang, MD

Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Fateeha Furqan, MBBS¹, Timothy S. Fenske, MD¹, Walter L. Longo, MD^1*, Bryon Johnson, PhD¹, Mehdi Hamadani, MD² and Nirav N. Shah, MD¹

¹Department of Hematology & Oncology, Medical College of Wisconsin, Milwaukee, WI
²The BMT & Cellular Therapy Program, Medical College of Wisconsin, Milwaukee, WI

Jana Karolova, MD^1,2*, Dmitry Kazantsev, PhD^2*, Michael Svaton, MD^3*, Liliana Tušková, MD^2*, Kristina Forsterova, MSc, PhD^4*, Diana Malarikova, MD^2,4*, Katerina Benesova, MD, CSc.^4*, Tomáš Heizer, Ing^2*, Alexandra Dolníková, MSc^2*, Magdalena Klanova, MD, PhD^2,4*, Eva Fronkova^3*, Marek Trněný, MD, prof⁴ and Pavel Klener Jr., Prof., MD, PhD^2,5*

¹First Department of Medicine - Hematology, General University Hospital Prague and First Faculty of Medicine, Charles University, Praha, Czech Republic
²Institute of Pathological Physiology, First Faculty of Medicine, Charles University, Prague, Czech Republic
³CLIP - Childhood Leukaemia Investigation Prague, Department of Paediatric Haematology and Oncology, Childhood Leukaemia Investigation Prague, Department of Pediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
⁴First Department of Medicine - Hematology, General University Hospital Prague and First Faculty of Medicine, Charles University, Prague, Czech Republic
⁵First Department of Internal Medicine - Hematology, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic

Baoyan Bai, PhD^1,2,3*, Jillian F. Wise, PhD^2,4,5,6,7, Daniel Vodák, BS^4*, Sigve Nakken, PhD^4,8,9,10*, Ankush Sharma, PhD^2,11*, Yngvild Nuvin Blaker, MD, PhD^2,11*, Marianne Brodtkorb, MD, PhD^12*, Vera Hilden^2,11*, Gunhild Trøen, PhD^13*, Weicheng Ren, PhD^14*, Suzanne Lorenz, PhD^15,16*, Michael S. Lawrence, PhD^5,7*, Ola Myklebost, PhD^4,10,17*, Eva Kimby, MD, PhD¹⁸, Qiang Pan-Hammarstrom, MD, PhD^19*, Leonardo Meza-Zepeda, PhD^4,10,15*, Klaus Beiske, MD, PhD^20*, Erlend B. Smeland, PhD, MD^2,11*, Eivind Hovig, PhD^4,8,10*, Ole Christian Lingjærde, PhD^8,21,22*, Harald Holte, MD, PhD^2,4,12 and June Helen Myklebust, PhD^2,11

¹Clinical Molecular Biology (EpiGen), Medical Division, Akershus University Hospital and Institute of Clinical Medicine, University of Oslo, Norway, OSLO, Norway
²KG. Jebsen Centre for B cell Malignancies, Institute for Clinical Medicine, University of Oslo, Oslo, Norway, Oslo, Norway
³Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, OSLO, Norway
⁴Norwegian Cancer Genomics Consortium, Oslo, Norway
⁵Broad Institute of Harvard and MIT, Cambridge, MA
⁶Cancer Center, Massachusetts General Hospital - Harvard Medical School - Broad Institute, Boston, MA
⁷Massachusetts General Hospital Cancer Center and Department of Pathology, Harvard Medical School, Charlestown, MA
⁸Department of Informatics, University of Oslo, Oslo, Norway
⁹Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
¹⁰Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway
¹¹Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway
¹²Department of Oncology, Oslo University Hospital, Oslo, Norway
¹³Department of Pathology, Oslo University Hospital, Oslo, Oslo, Norway
¹⁴Dept of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden
¹⁵Genomics Core Facility, Department of Core Facilities, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway
¹⁶Norwegian Cancer Genomics Consortium, Oslo, DC, Norway
¹⁷Department for Clinical Science, University of Bergen, Bergen, Norway
¹⁸Hematology, Karolinska Institute, Stockholm, Sweden
¹⁹Dept of Biosciences and Nutrition, Karolinska Institutet, Stockholm, SWE
²⁰Department of Pathology, Division of Cancer Medicine, Oslo University Hospital, Oslo, NOR
²¹KG. Jebsen Centre for B cell Malignancies, Institute for Clinical Medicine, University of Oslo, Oslo, Norway
²²Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway

Neil Ari Wijetunga, MD, PhD^1*, Emily S. Lebow, MD^1*, Jisun Lee^1*, Beatrice Fregonese, MPH^1*, Kathryn R. Tringale, MD, MAS^1*, Harper Hubbeling, MD¹, Reith Sarkar, MD^1*, Jennifer Ma, MD^1*, Venkatraman Seshan, PhD^2*, Erel Joffe, MD, MSc³, Ahmet Dogan, MD, PhD⁴, Alexander Chan, MD^5*, Guido Wendel, MD^6*, Carla Hajj, MD^1*, Brandon S. Imber, MD¹ and Joachim Yahalom, MD¹

¹Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
²Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
³Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Department of Pathology and Laboratory Medicine, Hematopathology Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁵Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY
⁶Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, NY

Xinhua Wang, MD, PhD^1,2,3,4*, Zhiming Li^5*, Yu Chang^1,6*, Shiyong Li^7*, Wei Wu^8*, Fangyuan Chang^9*, Yinyin Chang^10*, Dandan Zhu^10*, Mingzhi Zhang, MD, PhD¹ and Mao Mao, MD, PhD^11,12

¹Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
²Department of Oncology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
³The First Affiliated Hospital of Zhengzhou University, zhengzhou, China
⁴Department of Oncology, The First Affifiliated Hospital of Zhengzhou University; Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, China
⁵Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China
⁶The first affiliated hospital of Zhengzhou University, zhengzhou, China
⁷SeekIn Inc., Shenzhen, China
⁸SeekIn Inc, Shenzhen, China
⁹Shenyou Bio, Zhengzhou, China
¹⁰Clinical Laboratories, Shenyou Bio, Zhengzhou, China
¹¹Yonsei Song-Dang Institute for Cancer Research, Yonsei University, Seoul, Korea, Republic of (South)
¹²Seekin, Shenzhen, China

Vit Prochazka, Prof., MD, PhD^1*, Jan Grohmann, Dr.^2*, Veronika Hanackova, MD^3*, Alexandra Kredatusova, MD^2*, Jana Navratilova, Dr.^2*, Helena Urbankova, Dr., PhD.^4*, Tomáš Papajík, MD, CSc, Prof^5* and Veronika Bachanova, MD, PhD⁶

¹Dept. of Hemato-Oncology, University Hospital Olomouc, Olomouc, Czech Republic
²Dept. of Hemato-Oncology, University Hosp Olomouc, Olomouc, Czech Republic
³Dept of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University and University Hospital, OLOMOUC, Czech Republic
⁴Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacký University and University Hospital Olomouc, Olomouc, Czech Republic
⁵Department of Hemato-oncology, Faculty Hospital and Faculty of Medicine and Dentistry, Palacký University, Olomouc, Czech Republic
⁶Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN

Agnieszka Malecka, PhD^1,2,3*, Ingunn Ostlie^1*, Gunhild Trøen, PhD^1*, Jędrzej M. Małecki, PhD^4*, Jan Delabie, MD, PhD^5*, Anne Tierens, MD, PhD⁶, Sigbjørn Berentsen, MD, PhD^7* and Geir E Tjønnfjord, MD^2,3

¹Department of Pathology, Oslo University Hospital, Oslo, Norway
²Department of Haematology, Oslo University Hospital, Oslo, Norway
³KG Jebsen Centre for B-cell Malignancies and Institute of Clinical Medicine, University of Oslo, Oslo, Norway
⁴Department of Biosciences, University of Oslo, Oslo, Norway
⁵University Health Network, Princess Margaret Cancer Center, Toronto, ON, Canada
⁶Laboratory Medicine Program, University Health Network, Toronto, ON, Canada
⁷Department of Research and Innovation, Haugesund Hospital, Haugesund, Norway

Tomohiro Urata^1*, Kazutaka Sunami², Toshi Imai, MD^3*, Yuichiro Nawa, MD^4*, Yasushi Hiramatsu, MD, PhD^5*, Kazuhiko Yamamoto, MD, PhD^6*, Soichiro Fujii, MD^7*, Isao Yoshida, MD, PhD^8*, Tomofumi Yano, MD^9*, Yusuke Naoi, MD^10*, Kazuhiro Ikeuchi, MD^11*, Hiroki Kobayashi, MD^11*, Katsuma Tani, MD^11*, Shuji Momose, MD, PhD^12*, Jun-ichi Tamaru, MD, PhD^12*, Merrill Boyle^13*, Aixiang Jiang, MSc^14*, Yasuharu Sato, MD^15*, Tadashi Yoshino, MD, PhD^10*, Yoshinobu Maeda, MD, PhD^11,16, David W. Scott, PhD, MD, FRACP, FRCPA¹⁷ and Daisuke Ennishi, MD, PhD¹⁸

¹Department of Hematology and Oncology, Okayama University, Okayama, OKA, Japan
²Department of Hematology, National Hospital Organization Okayama Medical Center, Okayama, Japan
³Department of Hematology and Blood Transfusion, Kochi Health Sciences Center, Kochi, Japan
⁴Ehime Prefectural Central Hosp., Matsuyama, JPN
⁵Department of Hematology and Oncology, Japanese Red Cross Society Himeji Hospital, Himeji, Japan
⁶Department of Hematology/Oncology, Okayama City Hospital, Okayama, Japan
⁷Department of Hematology, Japanese Red Cross Okayama Hospital, Okayama, Japan
⁸Department of Hematologic Oncology, National Hospital Organization Shikoku Cancer Center, Mastuyama, Japan
⁹Department of Internal Medicine, Okayama Rosai Hospital, Okayama, JPN
¹⁰Department of Pathology, Okayama University Graduate School of Medicine, Okayama, Japan
¹¹Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan
¹²Department of Pathology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan
¹³BC Cancer Agency, Vancouver, BC, CAN
¹⁴Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada
¹⁵Okayama University Graduate School of Medicine, Okayama, Japan
¹⁶Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
¹⁷British Columbia Cancer Agency, Vancouver, BC, Canada
¹⁸Department of Hematology and Oncology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan

Omar Jabado, PhD^1*, Christopher Chiu, PhD¹, Matthew Loya, BS^1*, Manling Ma-Edmonds, MS^1*, David Soong, PhD², Anantharaman Muthuswamy, DVM, PhD^1*, Mahesh Bachu, PhD^1*, Nicole Bottrel, MS^1*, Han Si, PhD^2*, Jimin Zhang, PhD^1*, Monica Wielgos-Bonvallet, PhD^1*, Julie Blædel, MD^3*, Erin Henitz, MSc^1*, Brandon Higgs, PhD^2*, Kate Sasser, PhD¹, Suzana Couto, DVM, PhD^1*, Maria Jure-Kunkel, PhD, DVM^1* and Mark Fereshteh, PhD^1*

¹Translational Research and Precision Medicine Operations, Genmab, Princeton, NJ
²Translational Data Science, Genmab, Princeton, NJ
³Global Medical Affairs, Genmab, Copenhagen, Denmark

George W. Wright, PhD^1*, Colleen A. Ramsower, BS, MB(ASCP)^2*, James R. Cerhan, MD, PhD³, Anne J. Novak, PhD⁴, Brian K. Link, MD⁵, Matthew J. Maurer, MS, DMSc^6*, Raphael Mwangi, MS^7*, Allison C. Rosenthal, DO⁸, Thomas M. Habermann, MD⁹, Lou Staudt, MD, PhD¹⁰, Robert Kridel, MD¹¹, David W. Scott, PhD, MD, FRACP, FRCPA¹², Christian Steidl^13* and Lisa M. Rimsza, MD¹⁴

¹Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda
²Department of Research, Mayo Clinic, Scottsdale, AZ
³Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
⁴Division of Hematology, Mayo Clinic, Rochester, MN
⁵Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA
⁶Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, MN
⁷Department of Quantitative Health Sciences Research, Mayo Clinic, Rochester, MN
⁸Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ
⁹Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
¹⁰Lymphoid Malignancies Branch, Center for Cancer Research, NIH-National Cancer Institute, Bethesda, MD
¹¹University Health Network, Princess Margaret Cancer Center, Toronto, ON, Canada
¹²British Columbia Cancer Agency, Vancouver, BC, Canada
¹³Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada
¹⁴Division of Hematopathology, Mayo Clinic - Scottsdale, Scottsdale, AZ

Jun Rao^1*, Lin Xia^2*, Qiong Li^3*, Xinlei Li^3*, Naya Ma^3*, Lidan Zhu^4*, Li Gao^5* and Xi Zhang, M.D., Ph.D.^6*

¹Department of Hematology, Xinqiao Hospital, Army Medical University, Chongqing, China
²Medical Center of Hematology, Xinqiao Hospital, State Key Laboratory of Trauma,, Chongqing, CHN
³Xinqiao hospital, Chongqing, China
⁴Medical center of Hematology, Xinqiao Hospital, Army medical University, Chongqing, China
⁵Medical Center of Hematology, Xinqiao Hospital, Army Medical University，Chongqing, 400037, China, Chongqing, China
⁶Medical Center of Hematology, Xinqiao Hospital, State Key Laboratory of Trauma, Burn and Combined Injury, Army Medical University, Chongqing, China

Erika Gedvilaite, MA^1*, Sara DiNapoli, PhD^2*, Coleman Spence, BS^2*, Monica S. Diosdado, MA^2*, Anna Razumova, MBA^2*, Anita S. Bowman, MA^2*, Dana WY Tsui, PhD^2*, Gilles Salles, MD, PhD³, Connie Lee Batlevi, MD, PhD⁴, Gottfried von Keudell, MD, PhD⁵, Ryan Ptashkin, MS^1*, Ahmet Zehir, PhD^1*, Ryma Benayed, PhD^1*, Michael F. Berger, PhD^6*, A. Rose Brannon, PhD^2* and Maria E. Arcila, MD^7,8*

¹Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY
²Memorial Sloan Kettering Cancer Center, New York
³Memorial Sloan Kettering Cancer Center, New York, NY
⁴Lymphoma Service, Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, NEW YORK, NY
⁵Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁶Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
⁷Department of Pathology and Laboratory Medicine, Hematopathology Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁸Department of Pathology and Laboratory Medicine, Molecular Diagnostic Service, Memorial Sloan Kettering Cancer Center, New York, NY